A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years	DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 3	2023-09-18		NCT06041061

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centers for Disease Control and Prevention, China	7
Guangxi Center for Disease Control and Prevention	2
Henan Center for Disease Control and Prevention	7
Sichuan Center for Disease Control and Prevention	4
Sinocelltech Ltd.	32
Yunnan Center for Disease Control and Prevention	3

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangxi Center for Disease Control and Prevention	Nanning	China	1
Henan Center for Disease Control and Prevention	Zhengzhou	China	1
Shanxi Center for Disease Control and Prevention	Taiyuan	China	1
Sichuan Center for Disease Control and Prevention	Chengdu	China	3
Yunan Center for Disease Control and Prevention	Kunming	China	1